{"id":"viscosupplementation-1-1-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or swelling"},{"rate":null,"effect":"Transient joint effusion"},{"rate":null,"effect":"Local inflammation"}]},"_chembl":{"chemblId":"CHEMBL3301587","moleculeType":"Antibody"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This formulation combines hyaluronic acid components in a 1+1+1 ratio to create a viscoelastic fluid that mimics natural synovial fluid. It reduces friction between joint surfaces, absorbs shock, and may provide anti-inflammatory effects to alleviate pain and improve joint mobility in osteoarthritis.","oneSentence":"Viscosupplementation 1+1+1 is a hyaluronic acid-based intra-articular injection that restores joint lubrication and provides cushioning to damaged cartilage.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:15:15.445Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Osteoarthritis of the knee"},{"name":"Joint pain and dysfunction secondary to osteoarthritis"}]},"trialDetails":[{"nctId":"NCT05978180","phase":"NA","title":"Safety of Use and Efficacy of Pandora for Patients Suffering From Gonarthrosis (PANDORA2)","status":"COMPLETED","sponsor":"Labrha","startDate":"2023-10-18","conditions":"Knee Osteoarthritis","enrollment":252},{"nctId":"NCT07237711","phase":"NA","title":"Clinical Investigation of Sensovisc","status":"NOT_YET_RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-11-25","conditions":"Osteo Arthritis of the Knee","enrollment":75},{"nctId":"NCT06433492","phase":"NA","title":"Safety and Efficacy of Viscosupplementation of Hyaluronic Acid With Addition of Lecithin in Patients With Mild or Moderate Osteoarthrosis of the Knee Joint.","status":"COMPLETED","sponsor":"Biovico Sp. z o.o.","startDate":"2020-12-30","conditions":"Osteoarthritis, Knee","enrollment":50},{"nctId":"NCT05492851","phase":"PHASE4","title":"Trial Comparing Three Single Dose Injections for Knee Osteoarthritis","status":"TERMINATED","sponsor":"Ohio State University","startDate":"2022-08-02","conditions":"Osteoarthritis, Knee","enrollment":6},{"nctId":"NCT01625013","phase":"NA","title":"Synvisc-One for Younger, Active Patients With Osteoarthritis","status":"COMPLETED","sponsor":"Anthony Luke","startDate":"2011-11","conditions":"Osteoarthritis","enrollment":51},{"nctId":"NCT03408145","phase":"NA","title":"Stem Cell and Growth Factor Injury and Arthritis Clinical Research Study","status":"COMPLETED","sponsor":"The Stone Research Foundation for Sports Medicine and Arthritis","startDate":"2018-01-04","conditions":"Osteoarthritis, Knee","enrollment":88},{"nctId":"NCT03762408","phase":"NA","title":"Efficacy and Safety of a Intra-articular Injection, ENKO1, in Patients With Symptomatic Knee Osteoarthritis.","status":"COMPLETED","sponsor":"OPKO Health, Inc.","startDate":"2017-12-15","conditions":"Osteoarthritis, Knee","enrollment":175},{"nctId":"NCT00971074","phase":"NA","title":"Study of Viscosupplementation for the Treatment of Knee Pain After Menisectomy","status":"WITHDRAWN","sponsor":"Grant Jones","startDate":"2009-12","conditions":"Arthralgia","enrollment":""},{"nctId":"NCT04017949","phase":"","title":"Do Knee Injections Offer Benefit With Knee Arthritis Pain","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2019-08-21","conditions":"Knee Osteoarthritis","enrollment":75},{"nctId":"NCT04019782","phase":"PHASE3","title":"Collagen-PVP vs Hylan G-F 20 in the Treatment of Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2019-08-01","conditions":"Knee Osteoarthritis, Gonarthrosis","enrollment":120},{"nctId":"NCT03801564","phase":"NA","title":"Knee Osteoarthritis: Platelet Rich Plasma or Hyaluronic Acid","status":"UNKNOWN","sponsor":"Antalya Training and Research Hospital","startDate":"2019-01-07","conditions":"Knee Osteoarthritis","enrollment":120},{"nctId":"NCT03679208","phase":"NA","title":"sAfety PerfoRmance chitOsan osteOarthritis ViscosupplEmentation","status":"UNKNOWN","sponsor":"Kiomed Pharma","startDate":"2018-10-15","conditions":"Knee Osteoarthritis","enrollment":100},{"nctId":"NCT03600571","phase":"PHASE4","title":"Injection Site Diversity Influences HA Distribution and Clinical Results in CP and KOA","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2014-08-30","conditions":"Osteoarthritis, Knee, Hyaluronan","enrollment":164},{"nctId":"NCT01670578","phase":"PHASE4","title":"Platelet-rich Plasma vs Viscosupplementation in the Treatment of Knee Articular Degenerative Pathology","status":"COMPLETED","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2009-02","conditions":"Knee Chondropathy, Osteoarthritis, Knee","enrollment":192},{"nctId":"NCT02613247","phase":"PHASE2","title":"Intra-articular Hyaluronic Acid Injection for Therapy-resistant Patellofemoral Pain Syndrome","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2016-03","conditions":"Patellofemoral Pain Syndrome","enrollment":50},{"nctId":"NCT02686047","phase":"PHASE2, PHASE3","title":"Comparing One Intraarticular Injection of a Novel HYAJOINT Plus With Synvisc-One for the Treatment of Knee OA","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2014-09","conditions":"Knee Osteoarthritis","enrollment":132},{"nctId":"NCT01824485","phase":"PHASE4","title":"Comparison of Two Application Regimens for Viscosupplementation","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2013-03","conditions":"Osteoarthritis","enrollment":104},{"nctId":"NCT01335321","phase":"PHASE4","title":"Evaluation of the Effect of Adding Corticosteroid to Viscosupplementation","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2011-03","conditions":"Osteoarthritis","enrollment":108},{"nctId":"NCT02197026","phase":"PHASE4","title":"Effectiveness and Safety of Synvisc® Versus Usual Treatments in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"1998-10","conditions":"Osteoarthritis","enrollment":518},{"nctId":"NCT01447303","phase":"","title":"Functional and Quality of Life Outcomes Following Viscosupplementation for Knee Osteoarthritis","status":"TERMINATED","sponsor":"University of Florida","startDate":"2009-08","conditions":"Knee Osteoarthritis","enrollment":43},{"nctId":"NCT01810809","phase":"PHASE4","title":"Hip Viscosupplementation: What is the Best Dosage?","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2013-04","conditions":"Osteoarthritis","enrollment":80},{"nctId":"NCT01748201","phase":"PHASE4","title":"Viscosupplementation in Patients With Hemophilic Arthropathy","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2012-11","conditions":"Osteoarthritis, Hemarthrosis, Hemophilia A","enrollment":13},{"nctId":"NCT01210742","phase":"NA","title":"The Efficacy of Viscosupplementation for Early Knee Osteoarthritis","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2011-05","conditions":"Knee Osteoarthritis","enrollment":60},{"nctId":"NCT01132677","phase":"NA","title":"A Study Comparing Viscosupplementation and Corticosteroid Injections for Knee Osteoarthritis","status":"UNKNOWN","sponsor":"LifeMark Health","startDate":"2010-05","conditions":"Osteoarthritis, Knee","enrollment":78},{"nctId":"NCT00330135","phase":"PHASE3","title":"The Efficacy Study of Sodium Hyaluronate to Treat Symptomatic Hip Osteoarthritis","status":"TERMINATED","sponsor":"Daiichi Sankyo","startDate":"2005-01","conditions":"Symptomatic Hip Osteoarthritis","enrollment":85}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["1+1+1"],"phase":"marketed","status":"active","brandName":"viscosupplementation 1+1+1","genericName":"viscosupplementation 1+1+1","companyName":"University of Sao Paulo General Hospital","companyId":"university-of-sao-paulo-general-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Viscosupplementation 1+1+1 is a hyaluronic acid-based intra-articular injection that restores joint lubrication and provides cushioning to damaged cartilage. Used for Osteoarthritis of the knee, Joint pain and dysfunction secondary to osteoarthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}